Dual inhibition of cannabinoid CB 1 receptor and inducible NOS attenuates obesity‐induced chronic kidney disease-Reference-Cited by-同舟云学术

Dual inhibition of cannabinoid CB 1 receptor and inducible NOS attenuates obesity‐induced chronic kidney disease

Published:2019-12-27 Issue:1 Volume:177 Page:110-127
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Udi Shiran¹,Hinden Liad¹,Ahmad Majdoleen¹,Drori Adi¹,Iyer Malliga R.²,Cinar Resat²^ORCID,Herman‐Edelstein Michal³⁴,Tam Joseph¹^ORCID

Affiliation:

1. Obesity and Metabolism Laboratory, Institute for Drug Research, School of Pharmacy, Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel

2. Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda MD USA

3. Department of Nephrology & Hypertension Rabin Medical Center Petah Tikva Israel

4. Sackler Medical School Tel Aviv University Tel Aviv Israel

Funder

FP7 Ideas: European Research Council

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14849

Reference63 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

2. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

3. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

4. Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy

5. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria in pathogenesis and therapy of renal fibrosis;Metabolism;2024-06

2. Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in mice;American Journal of Physiology-Renal Physiology;2024-06-01

3. The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis;Diabetology & Metabolic Syndrome;2024-02-15

4. Potential therapeutic medicines for renal fibrosis: Small-molecule compounds and natural products;Bioorganic Chemistry;2024-02

5. Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD;Journal of the American Society of Nephrology;2024-01-11